Bringing up peptides at a medical appointment feels awkward for a simple reason. Most people arrive with marketing language and leave without a clear picture of what is actually legal, prescribable, and covered. The fix is not a script. It is knowing the regulatory footing of each compound before you walk in, so the conversation stays grounded and your clinician can respond to specifics.
Here is what you can actually act on for the four peptides commonly raised in these visits: where each stands with the FDA, whether a licensed pharmacy can dispense it against a valid prescription, and what drives the price.
Two of these are approved drugs
Semaglutide and tirzepatide are the easiest to discuss because they are FDA-approved medications sold under brand names. That approval matters. It means a prescriber is working with a defined label, and a licensed pharmacy can fill the branded product through ordinary channels. Insurance coverage varies widely and often depends on the specific diagnosis on file, which is one reason costs feel unpredictable.
Compounded versions of these GLP-1 medications exist and enter and leave the market as shortage designations and regulatory positions shift. Whether a compounded form is available at any given moment is a legitimate question to ask a pharmacy directly, because the answer changes. Do not assume last year's situation still applies.
Tesamorelin is approved but narrower
Tesamorelin is also FDA-approved, but for a specific indication rather than general use. That narrows how and when a clinician can prescribe it and affects both availability and out-of-pocket cost. If a provider offers it casually for goals outside its labeled use, that is a signal to ask more questions, not fewer.
Thymosin alpha-1 sits in a different category
Thymosin alpha-1 is worth naming precisely because it does not share the status of the others. It is not an approved drug in the United States, and its place in compounding has been contested. Reading about it online can leave the impression that it is freely available. Treat any such claim with skepticism and confirm the current legal position with a licensed pharmacist before spending time or money.
What actually drives cost
Price differences between providers usually come from a few concrete places rather than quality alone.
- Whether you are getting an approved branded product or a compounded preparation
- Whether your insurance covers the specific indication, which shifts the entire out-of-pocket figure
- Pharmacy type, since a 503A pharmacy compounds for individual prescriptions and a 503B facility operates differently
- Bundled telehealth fees, which some providers fold into a single price and others itemize
When a quoted price seems far below or above the range you see elsewhere, the explanation almost always lives in that list. Ask which product you are actually receiving and where it is dispensed from.
How to vet a provider before you commit
A legitimate operation is comfortable answering plain questions. Who is the prescribing clinician, and are they licensed in your state? Which licensed pharmacy fills the prescription? Is the product an approved drug or a compounded preparation, and if compounded, from what type of facility? A provider that deflects any of these is telling you something.
You can also flip the awkwardness the other way. Instead of asking a clinician to endorse a peptide you found online, come with the regulatory status already understood and ask whether it fits your situation. That is a question a good clinician can answer, and it keeps the visit useful.
This is general information, not medical advice. Decisions about whether any of these compounds belong in your care should be made with a licensed clinician who knows your history.